Respiratory Infections News

BOSTON — GSK’s respiratory syncytial virus vaccine had a sustained effectiveness of around 67% among adults aged 60 years or older across two full RSV seasons, researchers reported at IDWeek.

COVID-19 vaccination was associated with a reduced likelihood of long COVID among children infected with SARS-CoV-2 during the omicron wave, according to study findings presented at IDWeek.

Hospitalized patients with multisystem inflammatory syndrome in children — or MIS-C —are far more likely to experience shock than those hospitalized with Kawasaki disease, according to a study.

BOSTON — Boosting with mRNA-1273 provided additional COVID-19 protection during the delta and omicron waves, and especially among older adults, according to data from the phase 3 coronavirus efficacy (COVE) trial presented at IDWeek.

BOSTON — Expanded use of wastewater surveillance confirmed spikes in clinical cases of COVID-19, influenza and respiratory syncytial virus in one of Canada’s largest cities, according to study findings presented at IDWeek.

BOSTON — Two doses of an experimental live-attenuated intranasal COVID-19 vaccine generated a robust immune response in a phase 1 trial, researchers reported.

Pfizer’s maternal vaccine against respiratory syncytial virus could significantly decrease clinical visits among infants and save more than $800 million in overall costs, according to a study presented at IDWeek.

Maternal pertussis vaccination resulted in a 66% decrease in pertussis among infants through age 6 months and remained protective for up to 8 months, with no evidence it blunted response to further vaccination, an Australian study found.

IDWeek relaxed its COVID-19 policies this year, no longer requiring that attendees wear a mask or provide proof of vaccination.

An NIH-funded study found a potential link between the combination of prenatal COVID-19 and maternal stress and an increased risk for impaired attention span in infants, according to findings reported in Pediatric Research.